|
1
|
Matsumoto T, Sakurai MH, Kiyohara H and
Yamada H: Orally administered decoction of Kampo (Japanese herbal)
medicine, ‘Juzen-Taiho-To’ modulates cytokine secretion and induces
NKT cells in mouse liver. Immunopharmacology. 46:149–161. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kiyohara H, Matsumoto T and Yamada H:
Combination effects of herbs in a multi-herbal formula: Expression
of Juzen-taiho-to's immuno-modulatory activity on the intestinal
immune system. Evid Based Complement Alternat Med. 1:83–91. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kiyohara H, Matsumoto T, Takemoto N,
Kawamura H, Komatsu Y and Yamada H: Effect of oral administration
of a pectic polysaccharide fraction from a Kampo (Japanese herbal)
medicine ‘juzen-taiho-to’ on antibody response of mice. Planta Med.
61:429–434. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iijima K, Sun S, Cyong JC and Jyonouchi H:
Juzen-taiho-to, a Japanese herbal medicine, modulates type 1 and
type 2 T cell responses in old BALB/c mice. Am J Chin Med.
27:191–203. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ohnishi Y, Fujii H, Hayakawa Y, Sakukawa
R, Yamaura T, Sakamoto T, Tsukada K, Fujimaki M, Nunome S, Komatsu
Y, et al: Oral administration of a Kampo (Japanese herbal) medicine
Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma
cells. Jpn J Cancer Res. 89:206–213. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Onishi Y, Yamaura T, Tauchi K, Sakamoto T,
Tsukada K, Nunome S, Komatsu Y and Saiki I: Expression of the
anti-metastatic effect induced by Juzen-taiho-to is based on the
content of Shimotsu-to constituents. Biol Pharm Bull. 21:761–765.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chino A, Sakurai H, Choo MK, Koizumi K,
Shimada Y, Terasawa K and Saiki I: Juzentaihoto, a Kampo medicine,
enhances IL-12 production by modulating Toll-like receptor 4
signaling pathways in murine peritoneal exudate macrophages. Int
Immunopharmacol. 5:871–882. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Munekage M, Ichikawa K, Kitagawa H,
Ishihara K, Uehara H, Watanabe J, Kono T and Hanazaki K: Population
pharmacokinetic analysis of daikenchuto, a traditional Japanese
medicine (Kampo) in Japanese and US health volunteers. Drug Metab
Dispos. 41:1256–1263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xie Y, Jiang ZH, Zhou H, Ma WZ, Wong YF,
Liu ZQ and Liu L: The pharmacokinetic study of sinomenine,
paeoniflorin and paeonol in rats after oral administration of a
herbal product Qingfu Guanjiesu capsule by HPLC. Biomed Chromatogr.
28:1294–1302. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Y, Ma Y and Ma W: Pharmacokinetics
and bioavailability of cinnamic acid after oral administration of
Ramulus Cinnamomi in rats. Eur J Drug Metab Pharmacokinet.
34:51–56. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao W-J, Wang BJ, Wei CM, Yuan GY, Bu FL
and Guo RC: Determination of glycyrrhetic acid in human plasma by
HPLC-MS method and investigation of its pharmacokinetics. J Clin
Pharm Ther. 33:289–294. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aranda F, Vacchelli E, Eggermont A, Galon
J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G and Galluzzi
L: Trial Watch: Peptide vaccines in cancer therapy. OncoImmunology.
2:e266212013. View Article : Google Scholar
|
|
13
|
Saiki I, Koizumi K, Goto H, Inujima A,
Namiki T, Raimura M, Kogure T, Tatsumi T, Inoue H, Sakai S, et al:
The long-term effects of a Kampo medicine, juzentaihoto, on
maintenance of antibody titer in elderly people after influenza
vaccination. Evid Based Complement Alternat Med. 2013:5680742013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reed SG, Orr MT and Fox CB: Key roles of
adjuvants in modern vaccines. Nat Med. 19:1597–1608. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bacik I, Cox JH, Anderson R, Yewdell JW
and Bennink JR: TAP (transporter associated with antigen
processing)-independent presentation of endogenously synthesized
peptides is enhanced by endoplasmic reticulum insertion sequences
located at the amino- but not carboxyl-terminus of the peptide. J
Immunol. 152:381–387. 1994.PubMed/NCBI
|
|
16
|
Harding CV: Class I MHC presentation of
exogenous antigens. J Clin Immunol. 16:90–96. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Babu JS, Nair S, Kanda P and Rouse BT:
Priming for virus-specific CD8+ but not CD4+
cytotoxic T lymphocytes with synthetic lipopeptide is influenced by
acylation units and liposome encapsulation. Vaccine. 13:1669–1676.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takahashi H, Takeshita T, Morein B, Putney
S, Germain RN and Berzofsky JA: Induction of CD8+
cytotoxic T cells by immunization with purified HIV-1 envelope
protein in ISCOMs. Nature. 344:873–875. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Snapper CM and Paul WE: Interferon-gamma
and B cell stimulatory factor-1 reciprocally regulate Ig isotype
production. Science. 236:944–947. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu Z, Zan H, Pone EJ, Mai T and Casali P:
Immunoglobulin class-switch DNA recombination: Induction, targeting
and beyond. Nat Rev Immunol. 12:517–531. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gajewski TF and Fitch FW:
Anti-proliferative effect of IFN-gamma in immune regulation. I
IFN-gamma inhibits the proliferation of Th2 but not Th1 murine
helper T lymphocyte clones. J Immunol. 140:4245–4252.
1988.PubMed/NCBI
|
|
22
|
van der Bruggen P, Traversari C, Chomez P,
Lurquin C, De Plaen E, Van den Eynde BJ, Knuth A and Boon T: A gene
encoding an antigen recognized by cytolytic T lymphocytes on a
human melanoma. J Immunol. 178:2617–2621. 2007.PubMed/NCBI
|
|
23
|
Uezono Y, Miyano K, Sudo Y, Suzuki M,
Shiraishi S and Terawaki K: A review of traditional Japanese
medicines and their potential mechanism of action. Curr Pharm Des.
18:4839–4853. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamakawa J, Motoo Y, Moriya J, Ogawa M,
Uenishi H, Akazawa S, Sasagawa T, Nishio M and Kobayashi J:
Significance of Kampo, traditional Japanese medicine, in supportive
care of cancer patients. Evid Based Complement Alternat Med.
2013:7464862013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Okumi H and Koyama A: Kampo medicine for
palliative care in Japan. Biopsychosoc Med. 8:62014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suzuki H, Asakawa A, Amitani H, Fujitsuka
N, Nakamura N and Inui A: Cancer cachexia pathophysiology and
translational aspect of herbal medicine. Jpn J Clin Oncol.
43:695–705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iwase S, Yamaguchi T, Miyaji T, Terawaki
K, Inui A and Uezono Y: The clinical use of Kampo medicines
(traditional Japanese herbal treatments) for controlling cancer
patients' symptoms in Japan: A national cross-sectional survey. BMC
Complement Altern Med. 12:2222012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mantani N, Kasahara Y, Kamata T, Sekiya N,
Shimada Y, Usuda K, Sakakibara I, Hattori N and Terasawa K: Effect
of Seihai-to, a Kampo medicine, in relapsing aspiration pneumonia -
an open-label pilot study. Phytomedicine. 9:195–201. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hayashi A, Wakita H, Yoshikawa T,
Nakanishi T, Tsutsumi Y, Mayumi T, Mukai Y, Yoshioka Y, Okada N and
Nakagawa S: A strategy for efficient cross-presentation of
CTL-epitope peptides leading to enhanced induction of in vivo tumor
immunity. J Control Release. 117:11–19. 2007. View Article : Google Scholar
|
|
30
|
Kato S, Koizumi K, Yamada M, Inujima A,
Takeno N, Nakanishi T, Sakurai H, Nakagawa S and Saiki I: A
phagocytotic inducer from herbal constituent, pentagalloylglucose
enhances lipoplex-mediated gene transfection in dendritic cells.
Biol Pharm Bull. 33:1878–1885. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nakanishi T, Hayashi A, Kunisawa J,
Tsutsumi Y, Tanaka K, Yashiro-Ohtani Y, Nakanishi M, Fujiwara H,
Hamaoka T and Mayumi T: Fusogenic liposomes efficiently deliver
exogenous antigen through the cytoplasm into the MHC class I
processing pathway. Eur J Immunol. 30:1740–1747. 2000. View Article : Google Scholar : PubMed/NCBI
|
